Sound waves may restore erections after pelvic fracture

NCT ID NCT07460167

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested low-intensity shock wave therapy (LiSWT) in 25 men with erectile dysfunction after a pelvic fracture and urethral injury. The treatment uses a device that delivers gentle shock waves to the penis to improve blood flow. Researchers measured changes in penile blood flow and erectile function scores over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
low-intensity shock wave therapy (LiSWT) device
What this could lead to
If it works, this could offer a non-drug treatment option for erectile dysfunction after pelvic injury.
What could go wrong
This is a very small pilot study with only 25 participants and no control group. Results may not apply to everyone, and the therapy may not work for all.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

25 people

The number who actually took part.

Started

Jul 2023

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 months and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient with erectile dysfunction post pelvic fracture associated with urethral injury as estimated via urethrography or endoscopy, managed by urethroplasty and proceed for LiSWT sessions, 3 months post operative. * Age 18-70 years. * Patient is able and willing to sign informed consent \& complete all study requirements. Exclusion Criteria: * Previous hypospadias surgery. * Previous surgery for congenital curvature or Peyronie's disease. * Previous pelvic irradiation therapy. * Known grave psychiatric disorder. * Haemophilia or any other clotting disorder that causes bleeding diathesis. * Use of medication to increase erectile function, such as phosphodiesterase type 5 inhibitors and intracavernous injections, during the study. * Other causes of erectile dysfunction either physical causes as diabetes mellitus, hypertension, cardiovascular disease \& emotional causes. * Any condition or situation that, in the investigator's opinion, puts the patient at significant risk, could confound the study results, or could interfere significantly with the patient's participation in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Erectile dysfunction are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • South Valley University

    Qina, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.